United States Mitomycin C Market Report 2017

November 2017 | 100 pages | ID: U5914898905EN
QYResearch

Abstracts

In this report, the United States Mitomycin C market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Mitomycin C in these regions, from 2012 to 2022 (forecast).

United States Mitomycin C market competition by top manufacturers/players, with Mitomycin C sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Kyowa-kirin
• Intas Pharmaceuticals
• Teva
• Bristol-Myers Squibb
• Aspen
• Speciality European Pharma
• Alkem Laboratories
• Varifarma
• APOGEPHA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 2 Mg
• 10 Mg
• 40 Mg
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Mitomycin C for each application, including

• Cancer Treatment
• Ophthalmic Use
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Mitomycin C Market Report 2017

1 MITOMYCIN C OVERVIEW

1.1 Product Overview and Scope of Mitomycin C
1.2 Classification of Mitomycin C by Product Category
  1.2.1 United States Mitomycin C Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Mitomycin C Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 2 Mg
  1.2.4 10 Mg
  1.2.5 40 Mg
  1.2.6 Other
1.3 United States Mitomycin C Market by Application/End Users
  1.3.1 United States Mitomycin C Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer Treatment
  1.3.3 Ophthalmic Use
  1.3.4 Others
1.4 United States Mitomycin C Market by Region
  1.4.1 United States Mitomycin C Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Mitomycin C Status and Prospect (2012-2022)
  1.4.3 Southwest Mitomycin C Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Mitomycin C Status and Prospect (2012-2022)
  1.4.5 New England Mitomycin C Status and Prospect (2012-2022)
  1.4.6 The South Mitomycin C Status and Prospect (2012-2022)
  1.4.7 The Midwest Mitomycin C Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Mitomycin C (2012-2022)
  1.5.1 United States Mitomycin C Sales and Growth Rate (2012-2022)
  1.5.2 United States Mitomycin C Revenue and Growth Rate (2012-2022)

2 UNITED STATES MITOMYCIN C MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Mitomycin C Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Mitomycin C Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Mitomycin C Average Price by Players/Suppliers (2012-2017)
2.4 United States Mitomycin C Market Competitive Situation and Trends
  2.4.1 United States Mitomycin C Market Concentration Rate
  2.4.2 United States Mitomycin C Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Mitomycin C Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MITOMYCIN C SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Mitomycin C Sales and Market Share by Region (2012-2017)
3.2 United States Mitomycin C Revenue and Market Share by Region (2012-2017)
3.3 United States Mitomycin C Price by Region (2012-2017)

4 UNITED STATES MITOMYCIN C SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Mitomycin C Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Mitomycin C Revenue and Market Share by Type (2012-2017)
4.3 United States Mitomycin C Price by Type (2012-2017)
4.4 United States Mitomycin C Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MITOMYCIN C SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Mitomycin C Sales and Market Share by Application (2012-2017)
5.2 United States Mitomycin C Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MITOMYCIN C PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Kyowa-kirin
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Mitomycin C Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Kyowa-kirin Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Intas Pharmaceuticals
  6.2.2 Mitomycin C Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Intas Pharmaceuticals Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.2 Mitomycin C Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bristol-Myers Squibb
  6.4.2 Mitomycin C Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bristol-Myers Squibb Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aspen
  6.5.2 Mitomycin C Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aspen Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Speciality European Pharma
  6.6.2 Mitomycin C Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Speciality European Pharma Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Alkem Laboratories
  6.7.2 Mitomycin C Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Alkem Laboratories Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Varifarma
  6.8.2 Mitomycin C Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Varifarma Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 APOGEPHA
  6.9.2 Mitomycin C Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 APOGEPHA Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 MITOMYCIN C MANUFACTURING COST ANALYSIS

7.1 Mitomycin C Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Mitomycin C

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Mitomycin C Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Mitomycin C Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MITOMYCIN C MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Mitomycin C Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Mitomycin C Sales Volume Forecast by Type (2017-2022)
11.3 United States Mitomycin C Sales Volume Forecast by Application (2017-2022)
11.4 United States Mitomycin C Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Mitomycin C
Figure United States Mitomycin C Market Size (K Units) by Type (2012-2022)
Figure United States Mitomycin C Sales Volume Market Share by Type (Product Category) in 2016
Figure 2 Mg Product Picture
Figure 10 Mg Product Picture
Figure 40 Mg Product Picture
Figure Other Product Picture
Figure United States Mitomycin C Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Mitomycin C by Application in 2016
Figure Cancer Treatment Examples
Table Key Downstream Customer in Cancer Treatment
Figure Ophthalmic Use Examples
Table Key Downstream Customer in Ophthalmic Use
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Mitomycin C Market Size (Million USD) by Region (2012-2022)
Figure The West Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Mitomycin C Sales (K Units) and Growth Rate (2012-2022)
Figure United States Mitomycin C Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Mitomycin C Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Mitomycin C Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Mitomycin C Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Mitomycin C Sales Share by Players/Suppliers
Figure 2017 United States Mitomycin C Sales Share by Players/Suppliers
Figure United States Mitomycin C Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Mitomycin C Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Mitomycin C Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Mitomycin C Revenue Share by Players/Suppliers
Figure 2017 United States Mitomycin C Revenue Share by Players/Suppliers
Table United States Market Mitomycin C Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Mitomycin C Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Mitomycin C Market Share of Top 3 Players/Suppliers
Figure United States Mitomycin C Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Mitomycin C Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Mitomycin C Product Category
Table United States Mitomycin C Sales (K Units) by Region (2012-2017)
Table United States Mitomycin C Sales Share by Region (2012-2017)
Figure United States Mitomycin C Sales Share by Region (2012-2017)
Figure United States Mitomycin C Sales Market Share by Region in 2016
Table United States Mitomycin C Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Mitomycin C Revenue Share by Region (2012-2017)
Figure United States Mitomycin C Revenue Market Share by Region (2012-2017)
Figure United States Mitomycin C Revenue Market Share by Region in 2016
Table United States Mitomycin C Price (USD/Unit) by Region (2012-2017)
Table United States Mitomycin C Sales (K Units) by Type (2012-2017)
Table United States Mitomycin C Sales Share by Type (2012-2017)
Figure United States Mitomycin C Sales Share by Type (2012-2017)
Figure United States Mitomycin C Sales Market Share by Type in 2016
Table United States Mitomycin C Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Mitomycin C Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Mitomycin C by Type (2012-2017)
Figure Revenue Market Share of Mitomycin C by Type in 2016
Table United States Mitomycin C Price (USD/Unit) by Types (2012-2017)
Figure United States Mitomycin C Sales Growth Rate by Type (2012-2017)
Table United States Mitomycin C Sales (K Units) by Application (2012-2017)
Table United States Mitomycin C Sales Market Share by Application (2012-2017)
Figure United States Mitomycin C Sales Market Share by Application (2012-2017)
Figure United States Mitomycin C Sales Market Share by Application in 2016
Table United States Mitomycin C Sales Growth Rate by Application (2012-2017)
Figure United States Mitomycin C Sales Growth Rate by Application (2012-2017)
Table Kyowa-kirin Basic Information List
Table Kyowa-kirin Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyowa-kirin Mitomycin C Sales Growth Rate (2012-2017)
Figure Kyowa-kirin Mitomycin C Sales Market Share in United States (2012-2017)
Figure Kyowa-kirin Mitomycin C Revenue Market Share in United States (2012-2017)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Intas Pharmaceuticals Mitomycin C Sales Growth Rate (2012-2017)
Figure Intas Pharmaceuticals Mitomycin C Sales Market Share in United States (2012-2017)
Figure Intas Pharmaceuticals Mitomycin C Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Mitomycin C Sales Growth Rate (2012-2017)
Figure Teva Mitomycin C Sales Market Share in United States (2012-2017)
Figure Teva Mitomycin C Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Mitomycin C Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Mitomycin C Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Mitomycin C Revenue Market Share in United States (2012-2017)
Table Aspen Basic Information List
Table Aspen Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aspen Mitomycin C Sales Growth Rate (2012-2017)
Figure Aspen Mitomycin C Sales Market Share in United States (2012-2017)
Figure Aspen Mitomycin C Revenue Market Share in United States (2012-2017)
Table Speciality European Pharma Basic Information List
Table Speciality European Pharma Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Speciality European Pharma Mitomycin C Sales Growth Rate (2012-2017)
Figure Speciality European Pharma Mitomycin C Sales Market Share in United States (2012-2017)
Figure Speciality European Pharma Mitomycin C Revenue Market Share in United States (2012-2017)
Table Alkem Laboratories Basic Information List
Table Alkem Laboratories Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alkem Laboratories Mitomycin C Sales Growth Rate (2012-2017)
Figure Alkem Laboratories Mitomycin C Sales Market Share in United States (2012-2017)
Figure Alkem Laboratories Mitomycin C Revenue Market Share in United States (2012-2017)
Table Varifarma Basic Information List
Table Varifarma Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Varifarma Mitomycin C Sales Growth Rate (2012-2017)
Figure Varifarma Mitomycin C Sales Market Share in United States (2012-2017)
Figure Varifarma Mitomycin C Revenue Market Share in United States (2012-2017)
Table APOGEPHA Basic Information List
Table APOGEPHA Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure APOGEPHA Mitomycin C Sales Growth Rate (2012-2017)
Figure APOGEPHA Mitomycin C Sales Market Share in United States (2012-2017)
Figure APOGEPHA Mitomycin C Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mitomycin C
Figure Manufacturing Process Analysis of Mitomycin C
Figure Mitomycin C Industrial Chain Analysis
Table Raw Materials Sources of Mitomycin C Major Players/Suppliers in 2016
Table Major Buyers of Mitomycin C
Table Distributors/Traders List
Figure United States Mitomycin C Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Mitomycin C Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Mitomycin C Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Mitomycin C Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Mitomycin C Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Mitomycin C Sales Volume (K Units) Forecast by Type in 2022
Table United States Mitomycin C Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Mitomycin C Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Mitomycin C Sales Volume (K Units) Forecast by Application in 2022
Table United States Mitomycin C Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Mitomycin C Sales Volume Share Forecast by Region (2017-2022)
Figure United States Mitomycin C Sales Volume Share Forecast by Region (2017-2022)
Figure United States Mitomycin C Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources